Recognition of bacterial glycosphingolipids by natural killer T cells

Nature

Volumn 434, Issue 7032, 2005, Pages 520-525

  Kinjo, Yuki ^a   Wu, Douglass ^b   Kim, Gisen ^a   Xing, Guo Wen ^b   Poles, Michael A ^c,d   Ho, David D ^d   Tsuji, Moriya ^c,d   Kawahara, Kazuyoshi ^e,f   Wong, Chi Huey ^b   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e KITASATO INSTITUTE   (Japan)

^f KANTO GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BACTERIA; IMMUNOLOGY; MICROORGANISMS; PATTERN RECOGNITION; POLYSACCHARIDES;

NATURAL KILLER T (NKT) CELLS; SECRETION; T-CELL ANTIGEN RECEPTORS (TCR); TOLL-LIKE RECEPTOR 4;

CELLS;

BACTERIAL ANTIGEN; CD1 ANTIGEN; CD69 ANTIGEN; CYTOKINE; GALACTURONIC ACID; GAMMA INTERFERON; GLUCOSYLCERAMIDE; GLUCURONIC ACID; GLYCOSPHINGOLIPID; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN RECEPTOR; SPHINGOSINE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; TOLL LIKE RECEPTOR 4; CD1D ANTIGEN;

IMMUNE SYSTEM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPHINGOMONAS; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DENDRITIC CELL; HYBRIDOMA; IMMUNOLOGY; LIVER; MICROBIOLOGY; SYNTHESIS; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD1; CELLS, CULTURED; DENDRITIC CELLS; GLYCOSPHINGOLIPIDS; HUMANS; HYBRIDOMAS; KILLER CELLS, NATURAL; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPHINGOMONAS; T-LYMPHOCYTE SUBSETS;

EID: 15844421595     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03407     Document Type: Article

References (30)

1. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. & Wakao, H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483-58 (2003).
2. Brigl, M. & Brenner, M. B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
3. Kawahara, K. et al. Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis. FEBS Lett. 292, 107-110 (1991).
4. Kawahara, K., Moll, H., Knirel, Y. A., Seydel, U. & Zahringer, U. Structural analysis of two glycosphingolipids from the lipopolysaccharide- lacking bacterium Sphingomonas capsulata. Eur. J. Biochem. 267, 1837-1846 (2000).
5. Kawahara, K., Kubota, M., Sato, N., Tsuge, K. & Seto, Y. Occurrence of an alpha-galacturonosylceramide in the dioxin-degrading bacterium Sphingomonas within. FEMS Microbiol. Lett. 214, 289-294 (2002).
6. Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H. & Koezuka, Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7, 529-534 (1995).
7. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 KKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
8. Brossay, L. et al. CD1d-mediated recognition of an α- galactosylcerimide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521-1528 (1998).
9. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306,1786-1789 (2004).
10. Neef, A., Witzenberger, R. & Kampfer, P. Detection of sphingomorads and in situ identification in activated sludge using 16S rRNA-targeted oligonucleotide probes. J. Ind. Microbiol. Biotechnol. 23, 261-267 (3999).
11. Sidobre, S. et al. The T cell antigen receptor expressed by Vα14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl Acad. Sci. USA 101, 12254-12259 (2004).
12. Matsuda, J. L. et al. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc. Natl Acad. Sci. USA 98, 12636-12641 (2001).
13. Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M. & Chapman, P. B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 373-181 (2003).
14. Schumann, J., Voyle, R. B., Wei, B. Y. & MacDonald, H. R. Cutting edge: influence of the TCR V β domain on the avidity of CD1d:α-gatactosytceramide binding by invariant Vα14 NKT cells. J. Immunol. 170, 5815-5819 (2003).
15. Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14-Jα81 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831-1839 (1998).
16. Fujii, S., Shimizu, K., Kronenberg, M. & Steinman, R. M. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide- loaded DCs. Nature Immunol. 3, 867-874 (2002).
17. Brossay, L. et al. Structural requirements for gatactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 161, 5124-5128 (1993).
18. Vincent, M. S., Gumperz, J. E. & Brenner, M. B. Understanding the function of CD1-restricted T cells. Nature Immunol. 4, 517-523 (2003).
19. Skold, M. & Behar, S. M. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71, 5447-5455 (2003).
20. Mempel, M. et al. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J. Immunol. 168, 365-371 (2002).
21. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. & Brenner, M. B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nature Immunol. 4, 1230-1237 (2003).
22. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl Acad. Sci. USA 101, 10685-10690 (2004).
23. Amprey, J. L. et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904 (2004).
24. + NKT cells in germ-free mice. Eur. J. Immunol. 30, 620-625 (2000).
25. Gonzalez-Aseguinolaza, G. et al. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195, 617-624 (2002).
26. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R. M. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267-279 (2003).
27. Cheroutre, H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu. Rev. Immunol. 22, 217-246 (2004).
28. Shaw, P. X., Goodyear, C. S., Chang, M. K., Witztum, J. L. & Silverman, G. J. The autoreactivity of antiphosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J. Immunol. 170, 6151-6157 (2003).
29. Matsuda, J. L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
30. Matsuda, J. L. et al. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl Acad. Sci. USA 100, 8395-8400 (2003).